UAE Weight Loss and Obesity Management Market Research Report: Forecast (2026-2032)

UAE Weight Loss and Obesity Management Market - By Product Type Dietary Supplements & Nutraceutical (Meal Replacements, Beverages, Supplements), Prescription & OTC Therapeutics, (RX anti-obesity dru... ... (RX anti-obesity drugs, OTC weight-loss products, Conjugated therapies), Others, By Service (Fitness Centers, Slimming Centers, Consulting Services, Online Weight Loss Programs), By Product Form (Tablets, Capsules, Liquids, Soft Gels, Powders, Premixes, Gummies & Jellies, Others), By Age Group (Under 18 years, 18–35 years, 35–50 years, Above 50 years), By Distribution Channel (Pharmacies, Online Market places, Supermarkets/Hypermarkets, Specialty Stores, Others), and others Read more

  • Healthcare
  • Jan 2026
  • 135
  • PDF, Excel, PPT

UAE Weight Loss and Obesity Management Market Report Key Takeaways:

  • The UAE Weight Loss and Obesity Management Market size was valued at around USD 48.12 million in 2025 and is projected to reach USD 112 million by 2032. The estimated CAGR from 2026 to 2032 is around 12.83%, indicating strong growth.
  • By product type, the dietary supplements & nutraceuticals segment represented 48% of the UAE Weight Loss and Obesity Management Market size in 2025.
  • By product form, the capsules hold around 34% share of the UAE Weight Loss and Obesity Management Market in 2025.
  • By region, Dubai leads the UAE Weight Loss and Obesity Management Market with a market share of around 54% in 2025.
  • By service, the online weight loss programs segment is projected to grow with a CAGR of around 18% during 2026-32.
  • The leading weight loss and obesity management companies in the UAE are Eli Lilly and Company, Novo Nordisk A/S, Dardoc Health Technologies Limited, VIVUS LLC, Herbalife Ltd., Alma Health, Nestlé Health Science S.A., Atkins Nutritionals, Inc., Glanbia plc, Dr. Nutrition, 21st Century Healthcare Inc., Clinical Products LLC, Abbott Laboratories SA, and others.

Market Insights & Analysis: UAE Weight Loss and Obesity Management Market (2026-2032):

The UAE Weight Loss and Obesity Management Market size was valued at around USD 48.12 million in 2025 and is projected to reach USD 112 million by 2032. Along with this, the market is estimated to grow at a CAGR of around 12.83% during the forecast period, i.e., 2026-32.

The UAE Weight Loss and Obesity Management Market is experiencing rapid growth, driven by pronounced regional disparities in obesity prevalence, accelerating adoption of digital health platforms, and long-term demographic projections that point to a structurally rising patient base.

Data from the Ministry of Health and Prevention (MoHAP) highlights the scale and geographic spread of obesity across the UAE, revealing a structurally embedded public health challenge. For instance, Abu Dhabi records an adult obesity rate of 35.9%, markedly higher than the national average of 27.8%, pointing to concentrated risk shaped by local lifestyle and dietary dynamics.

Similarly, Dubai, despite its strong wellness culture, still reports 22.2% adult obesity, demonstrating that urban affluence and health awareness do not insulate populations from metabolic risk. Sharjah follows closely at 24.4%, while the burden becomes even more pronounced across smaller emirates, where obesity exceeds 38% in Ras Al Khaimah and reaches 39.1% in Ajman and Fujairah. These disparities show that obesity transcends income, age, and geography, constituting a nationwide structural burden that demands scalable, region-sensitive weight-management solutions across the UAE.

Parallel to this epidemiological pressure, the integration of digital health tools is reshaping how weight-related conditions are monitored and managed. By service, the online weight loss programs segment is expanding at a CAGR of 18%, reflecting strong consumer preference for app-based coaching, virtual consultations, and data-driven lifestyle interventions. For example, in early 2025, Abu Dhabi’s Sahatna app surpassed 300,000 downloads, enabling access to approximately 870,000 lab results and 440,000 prescription records. Such platforms embed health tracking into daily routines, supporting continuous monitoring of lifestyle conditions and reinforcing a shift toward proactive, data-driven obesity management.

Long-term projections further reinforce the market’s growth trajectory. For example, Lancet-derived estimates indicate that overweight and obesity prevalence among UAE adults aged 25+ could rise from about 84% to nearly 94% among males and 95% among females by 2050. Among youth aged 15–24, prevalence is projected to climb from 62% to roughly 81% over the same period. These forecasts point to a rapidly expanding population requiring structured, long-term weight-management solutions.

Furthermore, institutionally, MoHAP’s continued enhancement of national health surveys (2024–2025) and development of obesity prevention frameworks signal sustained policy focus through 2030 and beyond. This data-driven governance model supports early intervention strategies, standardized clinical pathways, and scalable preventive programs.

The convergence of high regional obesity rates, technology-enabled care models, and stark long-term prevalence projections positions the UAE obesity management market for structural growth. These forces will continue to expand demand for clinical therapies, digital platforms, and integrated weight-management solutions across the country.

UAE Weight Loss and Obesity Management Market Recent Developments:

  • November 2025: Novo Nordisk UAE unveiled the “You Are The New Champion” initiative during the Dubai Fitness Challenge 2025, reinforcing a science-led approach to obesity care. The campaign promotes awareness, early screening, and long-term behavioral change, guiding individuals toward clinically validated weight-management pathways. It supports the UAE’s National Nutrition Strategy by reframing obesity as a chronic condition requiring structured, evidence-based intervention.
  • March 2025: VIVUS has launched QSYMIA® (phentermine/topiramate extended-release), marking its first Middle Eastern market entry for this prescription obesity treatment proven to support weight reduction when combined with diet and exercise. The approval expands therapeutic options for adults and adolescents aged 12+ struggling with obesity, aligning with UAE public health efforts to address rising obesity prevalence.

UAE Weight Loss and Obesity Management Market Scope:

 Category  Segments
By Product Type Dietary Supplements & Nutraceutical (Meal Replacements, Beverages, Supplements), Prescription & OTC Therapeutics, (RX anti-obesity drugs, OTC weight-loss products, Conjugated therapies), Others,
By Service Fitness Centers, Slimming Centers, Consulting Services, Online Weight Loss Programs
By Product Form Tablets, Capsules, Liquids, Soft Gels, Powders, Premixes, Gummies & Jellies, Others
By Age Group Under 18 years, 18–35 years, 35–50 years, Above 50 years
By Distribution Channel Pharmacies, Online Market places, Supermarkets/Hypermarkets, Specialty Stores, Others), and others

UAE Weight Loss and Obesity Management Market Drivers:

Increasing Rate of Obesity Augments Market Growth

The United Arab Emirates is experiencing a deepening public health challenge as obesity rates continue to rise across age groups and demographics, directly accelerating demand for structured weight-management solutions.

For instance, data released by the Ministry of Health and Prevention (MoHAP) shows that adult obesity prevalence reached 27.8% in early 2024, with a marked gender gap 30.6% among women versus 25.1% among men. The burden is even heavier among Emirati nationals, where obesity affects 36.9% of the population, compared with 26.3% among residents, reflecting both cultural and lifestyle-driven risk patterns.

Unhealthy consumption patterns remain deeply embedded in daily routines. For instance, the National Health and Nutrition Survey indicates that 27.3% of adults exceed recommended sugar intake, while 27.4% consume sugar-sweetened beverages every day. Such habits accelerate weight gain, elevate insulin resistance, and increase lifetime exposure to obesity-related metabolic diseases.

The challenge begins early. For instance, nearly 40% of children in the UAE are overweight or obese, reflecting early exposure to sedentary lifestyles and calorie-dense diets. This trajectory increases lifetime health risks and establishes a growing cohort that will require sustained clinical and preventive weight-management support.

The scale and persistence of obesity across adults and children are reshaping healthcare priorities in the UAE. This epidemiological pressure will continue to fuel sustained growth in demand for medical, digital, and preventive obesity management solutions nationwide.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. UAE Weight Loss and Obesity Management Market Policies, Regulations, and Product Standards
  5. UAE Weight Loss and Obesity Management Market Trends & Developments
  6. UAE Weight Loss and Obesity Management Market Dynamics
    1. Growth Drivers
    2. Challenges
  7. UAE Weight Loss and Obesity Management Market Hotspot & Opportunities
  8. UAE Weight Loss and Obesity Management Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Product Type– Market Size & Forecast 2022-2032, USD Million
        1. Dietary Supplements & Nutraceuticals
          1. Meal Replacements
          2. Beverages
          3. Supplements
        2. Prescription & OTC Therapeutics
          1. RX anti-obesity drugs
          2. OTC weight-loss products
          3. Conjugated therapies
        3. Others
      2. By Service – Market Size & Forecast 2022-2032, USD Million
        1. Fitness Centers
        2. Slimming Centers
        3. Consulting Services
        4. Online Weight Loss Programs
      3. By Product Form – Market Size & Forecast 2022-2032, USD Million
        1. Tablets
        2. Capsules
        3. Liquids
        4. Soft Gels
        5. Powders
        6. Premixes
        7. Gummies & Jellies
        8. Others
      4. By Age Group – Market Size & Forecast 2022-2032, USD Million
        1. Under 18 years
        2. 18–35 years
        3. 35–50 years
        4. Above 50 years
      5. By Distribution Channel – Market Size & Forecast 2022-2032, USD Million
        1. Pharmacies
        2. Online Market places
        3. Supermarkets/Hypermarkets
        4. Specialty Stores
        5. Others
      6.  By Region
        1.  Abu Dhabi & Al Ain
        2.  Dubai
        3.  Sharjah & Northern Emirates
      7. By Company
        1. Company Revenue Shares
        2. Competitor Characteristics
  9. UAE Dietary Supplements & Nutraceuticals Weight Loss and Obesity Management Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Units Sold (Thousand Units)
    2. Market Share & Outlook
      1. By Service – Market Size & Forecast 2022-2032, USD Million
      2. By Product Form – Market Size & Forecast 2022-2032, USD Million
      3. By Age Group – Market Size & Forecast 2022-2032, USD Million
      4. By Distribution Channel – Market Size & Forecast 2022-2032, USD Million
      5. By Region
  10. UAE Prescription & OTC Therapeutics Weight Loss and Obesity Management Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Units Sold (Thousand Units)
    2. Market Share & Outlook
      1. By Service – Market Size & Forecast 2022-2032, USD Million
      2. By Product Form – Market Size & Forecast 2022-2032, USD Million
      3. By Age Group – Market Size & Forecast 2022-2032, USD Million
      4. By Distribution Channel – Market Size & Forecast 2022-2032, USD Million
      5. By Region
  11. UAE Weight Loss and Obesity Management Market Key Strategic Imperatives for Success & Growth
  12. Competition Outlook
    1.  Company Profiles
      1. Eli Lilly and Company
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Novo Nordisk A/S
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Dardoc Health Technologies Limited  
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. VIVUS LLC
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Herbalife Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Alma Health
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Nestlé Health Science S.A.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Atkins Nutritionals, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Glanbia plc
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Dr. Nutrition
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. 21st Century Healthcare Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Clinical Products LLC
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Abbott Laboratories SA
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Others
  13. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .